Santa Monica, CA, United States of America

Rajul Jain

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Rajul Jain: Innovator in T Cell Therapy

Introduction

Rajul Jain is a prominent inventor based in Santa Monica, CA, known for his significant contributions to the field of T cell therapy. With a total of five patents to his name, Jain has focused on enhancing the efficacy of T cell treatments for patients in need.

Latest Patents

Among his latest patents, Jain has developed methods of conditioning patients for T cell therapy. This invention provides innovative approaches to increase the effectiveness of T cell therapy by conditioning patients through the administration of a combination of cyclophosphamide and fludarabine. Additionally, he has created diagnostic methods for T cell therapy, which include identifying patients who would respond well to the treatment and utilizing preconditioning agents to optimize patient responses.

Career Highlights

Throughout his career, Rajul Jain has worked with notable organizations such as Kite Pharma, Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these institutions has allowed him to contribute to groundbreaking advancements in medical therapies.

Collaborations

Jain has collaborated with esteemed colleagues, including William Go and Adrian I Bot, further enhancing the impact of his research and innovations in the field.

Conclusion

Rajul Jain's work in T cell therapy exemplifies the importance of innovation in medicine. His patents and career achievements reflect a commitment to improving patient outcomes through advanced therapeutic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…